Pharmacielo Stock

Pharmacielo P/E 2024

Pharmacielo P/E

0.87

Ticker

PCLO.V

ISIN

CA71716K1012

WKN

A2PCAX

As of Sep 20, 2024, Pharmacielo's P/E ratio was 0.87, a -143.28% change from the -2.01 P/E ratio recorded in the previous year.

The Pharmacielo P/E history

Pharmacielo Aktienanalyse

What does Pharmacielo do?

Pharmacielo Ltd is a company specializing in the production of medical cannabis products. The company is based in Canada, but its production facilities are located in Colombia, one of the most important cultivation areas for cannabis worldwide. The company was founded in 2014 by individuals with experience in commercial cultivation of crops. Its goal is to establish a safe and efficient production of medical cannabis in Colombia to ensure high-quality and affordable supply for patients worldwide. Pharmacielo Ltd's business model is based on the production and delivery of medical cannabis products to customers worldwide. The company produces cannabis flowers, extracts, and oils that are used to treat various medical conditions such as cancer, chronic pain, and neurological disorders. Pharmacielo Ltd works closely with the Colombian government to regulate and standardize the cultivation of medical cannabis to ensure high quality and purity of its products. The company has already received various certifications and approvals confirming the quality and safety of its products. Pharmacielo Ltd is divided into different divisions specializing in production and logistics. The "Production" division is responsible for the cultivation and harvesting of cannabis. Pharmacielo Ltd collaborates with various partners to ensure a large production capacity. The "Extraction" division is responsible for the production of medical cannabis extracts and oils. The dried cannabis flowers are dissolved in a liquid and then extracted to isolate the desired components. The "Logistics" division is responsible for the delivery of products to customers worldwide. The company works with various shipping service providers to ensure fast and reliable delivery of its products. Pharmacielo Ltd offers a wide range of products made from medical cannabis, including cannabis flowers in different varieties and sizes that can be selected based on individual needs. Additionally, products such as oils, extracts, and capsules are offered, which have a higher concentration of cannabinoids and are therefore particularly suitable for the treatment of serious illnesses such as cancer or epilepsy. Overall, Pharmacielo Ltd has become a leading company in the production and delivery of medical cannabis in recent years. The company works closely with the government and other companies to ensure a safe and reliable supply for patients worldwide. With its wide range of products and innovative production technology, Pharmacielo Ltd is well positioned to continue growing and meeting the needs of customers in the future. Pharmacielo ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Pharmacielo's P/E Ratio

The Price to Earnings (P/E) Ratio of Pharmacielo is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Pharmacielo's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Pharmacielo is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Pharmacielo’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Pharmacielo stock

What is the price-to-earnings ratio of Pharmacielo?

The price-earnings ratio of Pharmacielo is currently 0.87.

How has the price-earnings ratio of Pharmacielo changed compared to last year?

The price-to-earnings ratio of Pharmacielo has increased by -143.28% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Pharmacielo high compared to other companies?

Yes, the price-to-earnings ratio of Pharmacielo is high compared to other companies.

How does an increase in the price-earnings ratio of Pharmacielo affect the company?

An increase in the price-earnings ratio of Pharmacielo would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Pharmacielo affect the company?

A decrease in the price-earnings ratio of Pharmacielo would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Pharmacielo?

Some factors that influence the price-earnings ratio of Pharmacielo are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Pharmacielo pay?

Over the past 12 months, Pharmacielo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pharmacielo is expected to pay a dividend of 0 CAD.

What is the dividend yield of Pharmacielo?

The current dividend yield of Pharmacielo is .

When does Pharmacielo pay dividends?

Pharmacielo pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pharmacielo?

Pharmacielo paid dividends every year for the past 0 years.

What is the dividend of Pharmacielo?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pharmacielo located?

Pharmacielo is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharmacielo kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharmacielo from 9/20/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did Pharmacielo pay the last dividend?

The last dividend was paid out on 9/20/2024.

What was the dividend of Pharmacielo in the year 2023?

In the year 2023, Pharmacielo distributed 0 CAD as dividends.

In which currency does Pharmacielo pay out the dividend?

The dividends of Pharmacielo are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pharmacielo

Our stock analysis for Pharmacielo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharmacielo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.